SUPRIYA LIFESCIENCE
Back to Balance Sheet
|
SUPRIYA LIFESCIENCE Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹87 Cr | ₹80 Cr | ₹96 Cr | ₹100 Cr | ₹146 Cr |
What is the latest Total Current Liabilities ratio of SUPRIYA LIFESCIENCE ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹87 Cr |
| Mar2024 | ₹80 Cr |
| Mar2023 | ₹96 Cr |
| Mar2022 | ₹100 Cr |
| Mar2021 | ₹146 Cr |
How is Total Current Liabilities of SUPRIYA LIFESCIENCE Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹87 Cr | 9.58 | |
| Mar2024 | ₹80 Cr | -16.92 | |
| Mar2023 | ₹96 Cr | -3.93 | |
| Mar2022 | ₹100 Cr | -31.72 | |
| Mar2021 | ₹146 Cr | - | |
Compare Total Current Liabilities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹4,732.2 Cr | 0.8% | -11.4% | -18.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | 0.8% |
-11.4% |
-18.9% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses